Home/Filings/SCHEDULE 13D/A/0001437749-26-001671
SCHEDULE 13D/A//SEC Filing

NovaBay Pharmaceuticals, Inc. SCHEDULE 13D/A

Accession 0001437749-26-001671

CIK 0002028474other

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 8:12 PM ET

Size

18.4 KB

Accession

0001437749-26-001671

Issuer

Framework Ventures IV L.P.

CIK 0002028474

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0002028474

Filing Metadata

Form type
SCHEDULE 13D/A
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 8:12 PM ET
Size
18.4 KB